Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -36.77M | -32060.13% | $ 114.7K |
3/31/2025 | $ -33.96M | -8989.31% | $ 377.83K |
12/31/2024 | $ -33.79M | -2554.95% | $ 1.32M |
9/30/2024 | $ -45.24M | -2990.76% | $ 1.51M |
6/30/2024 | $ -40M | -1438.92% | $ 2.78M |
3/31/2024 | $ -39.57M | -1520.34% | $ 2.6M |
12/31/2023 | $ -41.88M | -1870.42% | $ 2.24M |
9/30/2023 | $ -26.86M | -655.97% | $ 4.09M |
6/30/2023 | $ -28.83M | -449.32% | $ 6.42M |
3/31/2023 | $ -26.83M | -211.52% | $ 12.68M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for SAB BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ -16.85M ] / Revenues [ $ 60.88M ]
(=) EBIT % [ -27.68% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |